Friday 6 November 2026 Export AVTR’s income statement to Excel — free account

Avantor, Inc.

AVTR Healthcare Medical Instruments & Supplies

Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024.

Revenue: +4.59%
EPS: +128.9%
Free cash flow: −9.03%
Total debt: −4.51%

Quarter to September 2026, against a year earlier

Insider buying

15.14 0.51 −3.26%

Follow AVTR

Alert me

Market cap: $10.3B
P/E: 30.3×
Fwd P/E: 34.8×
Dividend yield: —
F-score: 4/9
Altman Z: 1.55
Beneish M: −2.91
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Avantor, Inc. (AVTR) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, Avantor, Inc. (AVTR) trades at a price to free cash flow of 23.3×. Over the past ten years it has ranged from 8.5× (May 2019) to 36.2× (December 2019); the current reading is higher than 69% of that period. That is in line with the Medical Instruments & Supplies industry median of 23.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/AVTR/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="Avantor, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/AVTR/metrics/price-to-free-cash-flow">Avantor, Inc. (AVTR) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	15.8×	(23.85%)
FY2024	20.7×	(2.58%)
FY2023	21.2×	9.48%
FY2022	19.4×	(34.31%)
FY2021	29.5×	58.07%
FY2020	18.7×	(22.40%)
FY2019	24.1×	181.87%
FY2018	8.5×	0.00%
FY2017	8.5×	0.00%
FY2016	8.5×	—

Period	Price to free cash flow	Change
Sep 2026	23.2×	57.60%
Jun 2026	14.7×	21.98%
Mar 2026	12.1×	(23.40%)
Dec 2025	15.8×	(3.02%)
29 more quarters	Free account

Against its own ten years

Low 8.5× High 36.2×

Ten-year median 20.9×

Current reading's percentile 69

Company	Price to free cash flow
SOLV Solventum Corporation compare	n/m
BAX Baxter International Inc. compare	11.6×
ALGN Align Technology, Inc. compare	16.8×
COO The Cooper Companies, Inc. compare	18.1×
AVTR Avantor, Inc.	23.3×
ATR AptarGroup, Inc. compare	31.0×
BLCO Bausch + Lomb Corporation compare	31.4×
TFX Teleflex Incorporated compare	125×
RGEN Repligen Corporation compare	170×
Medical Instruments & Supplies industry median	23.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

Avantor, Inc. (AVTR) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on AVTR

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on AVTR

Stockrow Weekly